Viking Therapeutics Reports Fourth Quarter And Year-End 2016 Financial Results And Provides Corporate Update Post author:Sam Post published:March 21, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017 Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017) June 4, 2017 Siemens Summons Three Banks for IPO of Healthineers Unit October 25, 2017
It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017
Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017) June 4, 2017